Central Coast Medical Oncology Corporation

Santa Monica, California 93454

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Early-Stage Breast Carcinoma, Gastroesophageal Junction Adenocarcinoma, HER-2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer, Hormone Receptor Positive Tumor, Metastatic Gastric Adenocarcinoma, Urothelial Carcinoma

Studies at this site

• A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer — Completed
• A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer — Completed
• A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer — Completed
• A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer — Completed